IDENTIFYING THE BROADER VALUE OF VACCINES IN LOW AND MIDDLE INCOME COUNTRIES

Author(s)

van der Putten IM1, Hiligsmann M1, Paulus AT1, Hutubessy R2, Evers SM1
1Maastricht University, Maastricht, The Netherlands, 2World Health Organization, Geneva, Switzerland

OBJECTIVES Current economic evaluations of vaccine immunization strategies mainly concentrate on immediate health gains (measured in metrics such as QALYs or DALYs) and household cost savings. Vaccine immunization strategies, however, often take place within a broader societal context. In order to financially sustain these strategies, economic evaluations should not only encompass immediate health gains and household costs but also the ‘broader value of vaccines’. This study aims to identify the relevance of information with regard to the broader value of vaccines for decision makers in low and middle income countries.   METHODS Several methods were used to identify the broader value of vaccines including a literature review, a survey, interviews and consultations with experts. The long-term effects of those who were vaccinated and the effects experienced by society as a whole, including non-vaccinated community members, were included in a framework. RESULTS In total, twenty broader values in five different domains were identified.  The first domain included long-term productivity gains. These gains refer to the individual long-term productivity due to better physical and mental health as well as to the economic consequences of decisions made by households due to improved child survival.  The second domain consists of ecological values which are related to the decline of prevalence and incidence of vaccine related diseases. The third domain encompasses different types of equity considerations. The fourth domain includes the impact of vaccine strategies on other health interventions. Finally, the fifth domain includes macro-economic effects, such as the impact of vaccine immunization strategies on GDP tax revenues and overall government savings. CONCLUSIONS Several broader economic values outside the healthcare sector were identified. These results provide the input for the incorporation of these values in economic evaluations. Further research is needed to identify the most important broader values for national decision makers.

Conference/Value in Health Info

2014-11, ISPOR Europe 2014, Amsterdam, The Netherlands

Value in Health, Vol. 17, No. 7 (November 2014)

Code

PRM31

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Infectious Disease (non-vaccine)

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×